The increasing prevalence of biologic drugs in pipelines, coupled with the recent advances in computing power and modeling tools available, means biopharmaceutical companies are focussing on computational tools to enhance biologic drug development.
We are looking to partner with a select number of the following organisations to align with our focussed agenda:
- Software providers with experience in developing modeling tools for biologic drug development
- Contract research organisations providing outsourced computational development solutions
- Data management companies with the expertise to analyze and interpret computational modeling data
CDD for Biologics remains the only conference to concentrate on applying computational tools to the development of biologic drugs.
This is the ideal platform to both assess the needs of drug developers and to demonstrate your expertise in this emerging and nascent area.
Meet the decision-makers from pharma and biotech who are committed to accelerating the development of their biotherapeutic pipeline. Showcase your company’s expertise and become a partner of choice. Generate new business leads and source opportunities for partnerships. Act now to stay ahead of the curve and maximize the wealth of opportunity on offer.
To find out more, or to discuss bespoke partnership opportunities, contact us today at email@example.com.